This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Malathion

Authoring team

Malathion is used in the treatment of pediculosis and scabies.

Malathion 0.5% liquid is licensed for children, aged 6 months and above, and adults.

After topical application absorbed malathion is rapidly detoxified by plasma carboxylesterases. Over the next 7 days about 4.5% of a single dose applied to the skin is recovered from the urine.

In the treatment of scabies the British National Formulary recommends malathion should be applied twice, one week apart..

The aqueous solutions are preferred in children and in asthmatics. Alcoholic preparations cause irritation of excoriated skin and the genitalia.

Malathion is not contraindicated in pregnancy or breast-feeding.

The summary of product characteristics should be consulted before prescribing this drug.

Reference:

  1. Drugs and Therapeutics Bulletin (2002), 40 (6), 43-46.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.